PRACTICAL ONCOLOGY JOURNAL ›› 2009, Vol. 23 ›› Issue (2): 113-117.doi: 10.3969/j.issn.1002-3070.2009.02.004

Previous Articles     Next Articles

The role and significance of CD28 monoclonal antibody stimulating peripheral blood of patients with tumors of FOXP3+Treg cells

DU Yangyang ,Shen Liqin,WANG Yanru,LIU Yuhua,SUN Jie,ZHUANG Zhixiang,QIU Yuhua   

  1. Suzhou University Medical Biotechnology Research Institute,Suzhou 215007
  • Received:2009-02-19 Online:2009-04-20 Published:2012-02-21

Abstract: Objective To explore the change and significance of FOXP3+Treg within peripheral blood mononudear cells(PBMC),which stimulated by CD28 monoclonal antibody in tumor patients.Methods Ascites induced immune and pro-law chromatography for purification and preparation of the monoclonal antibody,Ficoll density gradient centrifugation to obtain peripheral blood PBMC,and/or stimulated by CD28 monoclonal antibody 10μg/mL after co-culture by immunofluorescence and flow cytometry analysis of FOXP3+ Treg,as well as the expression of FOXP3+Fas+Treg and FOXP3+ FasL+Treg.Results Immunofluorescence and flow cytometry showed that the peripheral blood of tumor patients with FOXP3+Treg expression ratio(6.208±2.754)%,while the control group(2.653±0.638)%.FOXP3+FasL+Treg cells activated by CD28 monoclonal antibody for the FasL expression(7.252± 2.23)%,and healthy control group(7.96± 2.938)% Before and after activation the ratio of FOXP3+Fas+Treg(1.467± 0.590)%,(3.692± 1.822)%.Conclusion The ratio of FOXP3+Treg within PBMC in tumor patients decreased(P<0.01)after stimulating by CD28 monoclonal antibody which suggested the patients immune function recover and improve.

CLC Number: